ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis

Contributed by: PR Newswire

Tags

Ananda-Pharma-Limited

More Like This

Phase 1 MRX1 Study Delivers Strong Headline Data

MRX1 Successfully Delivered to Clinical Trial Site

First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial

(Photo: Business Wire)

ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain

(Photo: Business Wire)

ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation

Gynica announces First-in-Human Clinical Trial of Novel IntraVag© Treatment for Endometriosis

PR Newswire associated0

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

Business Wire associated0

Ananda Scientific and Benta Sign Memorandum on Advancing Treatments for PTSD